Skip to main content
$1.51 $0.10 (7.1%)

04:00 PM EDT on 06/06/23

Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

CAPS Rating: 1 out of 5

The Company is a clinical-stage drug development company that discovers and develops novel, small molecule drugs for the treatment of inflammatory diseases, cancer and viral diseases.

Current Price $1.51 Mkt Cap $262.2M
Open $1.42 P/E Ratio -5.84
Prev. Close $1.51 Div. (Yield) $0.00 (0.0%)
Daily Range $1.41 - $1.58 Volume 2,539,792
52-Wk Range $0.64 - $2.04 Avg. Daily Vol. 3,078,726

Caps

How do you think NASDAQ:RIGL will perform against the market?

Add Stock to CAPS Watchlist

All Players

148 Outperform
57 Underperform
 

All-Star Players

24 Outperform
15 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:RIGL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Momentum21 (50.74)
Submitted April 05, 2013

Obviously this puts them in a tough spot with Fostamatinib but they do have a few bullets left to fire in 2013 along with some cash that was raised at the end of 2012. I think the offering priced at 9.50. Not saying I have much of a valuation model… More

ScreenerStizBear (46.33)
Submitted June 26, 2008

I simply used the screener to identify 1-star companies with the highest 52-week gain. The 1-star rating should mean they are bad companies and the 52-week gain should mean they are overpriced. We’ll see how it works!

Fools bullish on NASDAQ:RIGL are also bullish on:

Fools bearish on NASDAQ:RIGL are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about RIGL.

Recs

0
Member Avatar Bigsef77 (51.82) Submitted: 7/14/2020 5:45:53 PM : Outperform Start Price: $2.56 NASDAQ:RIGL Score: -120.64

COVID trials

Recs

0
Member Avatar raspoutine (< 20) Submitted: 6/4/2019 3:41:48 PM : Outperform Start Price: $2.14 NASDAQ:RIGL Score: -81.17

indication for their approved drug.

Recs

0
Member Avatar johnstrobel (71.82) Submitted: 9/26/2017 5:27:32 AM : Outperform Start Price: $2.39 NASDAQ:RIGL Score: -108.06

https://www.fool.com/investing/2017/08/19/3-top-biotech-stocks-under-5.aspx?source=itxsitmot0000001&lidx=1

Leaderboard

Find the members with the highest scoring picks in RIGL.

Score Leader

qubit15

qubit15 (24.80) Score: +511.91

The Score Leader is the player with the highest score across all their picks in RIGL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
qubit15 24.80 1/21/2009 Underperform NS $6.95 -78.27% +433.64% +511.91 0 Comment
robo2011 33.27 11/17/2008 Underperform NS $6.53 -76.88% +407.26% +484.14 0 Comment
anticitradeshort 26.97 4/20/2009 Underperform NS $6.43 -76.52% +404.50% +481.02 0 Comment
cybob2000 44.70 10/23/2008 Underperform 3W $15.64 -90.35% +385.31% +475.66 0 Comment
schwah8 98.55 10/13/2008 Underperform NS $18.26 -91.73% +363.82% +455.55 0 Comment
EV38biotech < 20 11/5/2008 Underperform 5Y $8.60 -82.44% +345.29% +427.74 0 Comment
Mynx828 68.40 9/17/2009 Underperform 5Y $7.45 -79.73% +300.43% +380.16 0 Comment
longtermgrowth09 51.15 12/17/2009 Underperform 5Y $8.97 -83.17% +285.75% +368.91 0 Comment
darksider389 86.12 7/7/2008 Underperform 3M $21.97 -93.13% +253.96% +347.09 0 Comment
flats66 64.14 8/14/2008 9/18/2009 Underperform 3Y $22.71 -93.35% +244.63% +337.98 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for RIGL.